Mylan in patent lawsuit
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.
Pharmaceuticals, Biotechnology and Life Sciences
Mylan’s subsidiaries were sued Warner Chilcott and Qualicaps in connection with the filing of an ANDA with the FDA for Mesalamine Delayed-release Capsules.
The Food and Drug Administration (FDA) revealed Thursday latest products it had found containing hidden drug ingredients.
The prescriber certification deadline for new Clozapine REMS Program has been extended from November 23 to December 14. Due to…
The Food and Drug Administration (FDA) has issued a notice in which it advises consumers not to purchase or use XForMan Plus,…
Judge Peter Kirwan of the Superior Court of California for the County of Santa Clara has granted Depomed motion for…
The U.S. Food and Drug Administration approved Narcan nasal spray on Wednesday. Narcan is the first FDA-approved nasal spray version of…
Eli Lilly and Merck are moving on with an existing oncology clinical trial collaboration to evaluate the safety and efficacy of the combination of Lilly’s Almita (pemetrexed for injection) and Merck’s Keytruda (pembrolizumab) in a pivotal Phase III study in first-line nonsquamous non-small cell lung cancer (NSCLC).
Sanofi will participate to Solutions COP21, the United Nations conference on climate change, as an official partner, a public exhibition in Paris.
Biofrontera has concluded the clinical phase 3 of BCC study as the last patient in the ongoing phase has had its final clinical visit.
The United States and New Zealand are the only two countries in the world that allow direct-to-consumer advertising of prescription drugs.